Allegheny Pain Management, PC

Altoona, Pennsylvania 16602

0 studies enrolling now · 9 studies all time

What they study most

Analgesia, Breakthrough Pain, Cancer, Chronic Low Back Pain, Chronic Noncancer Pain, Chronic Nonmalignant and Nonneuropathic Pain, Chronic Pain, Low Back Pain, Neuralgia, Postherpetic, Neuropathic Pain, Pain

Studies at this site

• RN624 For Pain Of Post-Herpetic Neuralgia — Completed
• Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain — Completed
• Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain — Completed
• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain — Stopped early
• OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients — Completed